Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.

Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ.

BMC Cancer. 2015 Jul 24;15:541. doi: 10.1186/s12885-015-1558-5.

2.

A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

Castilho JL, Levi JE, Luz PM, Cambou MC, Vanni T, de Andrade A, Derrico M, Veloso VG, Grinsztejn B, Friedman RK.

BMC Cancer. 2015 Jun 23;15:478. doi: 10.1186/s12885-015-1486-4.

3.

Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: some views from service providers.

Munthali AC, Ngwira BM, Taulo F.

Patient Prefer Adherence. 2015 Mar 24;9:501-8. doi: 10.2147/PPA.S69286. eCollection 2015.

4.

Integrating cervical cancer prevention initiatives with HIV care in resource-constrained settings: A formative study in Durban, South Africa.

Ports KA, Haffejee F, Mosavel M, Rameshbabu A.

Glob Public Health. 2015;10(10):1238-51. doi: 10.1080/17441692.2015.1008021. Epub 2015 Feb 5.

PMID:
25654190
5.

Structural and sociocultural factors associated with cervical cancer screening among HIV-infected African American women in Alabama.

Williams M, Moneyham L, Kempf MC, Chamot E, Scarinci I.

AIDS Patient Care STDS. 2015 Jan;29(1):13-9. doi: 10.1089/apc.2014.0063.

6.

International scientific collaboration in HIV and HPV: a network analysis.

Vanni T, Mesa-Frias M, Sanchez-Garcia R, Roesler R, Schwartsmann G, Goldani MZ, Foss AM.

PLoS One. 2014 Mar 28;9(3):e93376. doi: 10.1371/journal.pone.0093376. eCollection 2014.

7.

Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.

Cespedes MS, Kerns SL, Holzman RS, McLaren PJ, Ostrer H, Aberg JA.

HIV Clin Trials. 2013 Nov-Dec;14(6):292-302. doi: 10.1310/hct1406-292.

8.

Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

J Clin Virol. 2013 Dec;58(4):696-702. doi: 10.1016/j.jcv.2013.10.012. Epub 2013 Oct 18.

9.

HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mumbai, India: 12-month follow-up.

Isaakidis P, Pimple S, Varghese B, Khan S, Mansoor H, Ladomirska J, Sharma N, Silva ED, Metcalf C, Caluwaerts S, Alders P, Ntzani EE, Reid T.

Int J Womens Health. 2013 Aug 13;5:487-94. doi: 10.2147/IJWH.S47710. eCollection 2013.

10.

Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S.

Hum Immunol. 2013 Dec;74(12):1696-700. doi: 10.1016/j.humimm.2013.08.010. Epub 2013 Aug 21.

11.

Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.

Garcia-Chagollan M, Jave-Suarez LF, Haramati J, Sanchez-Hernandez PE, Aguilar-Lemarroy A, Bueno-Topete MR, Pereira-Suarez AL, Fafutis-Morris M, Cid-Arregui A, del Toro-Arreola S.

J Biomed Sci. 2013 Aug 16;20:60. doi: 10.1186/1423-0127-20-60.

12.

The impact of human immunodeficiency virus infection on cervical preinvasive and invasive neoplasia in South Africa.

van Bogaert LJ.

Ecancermedicalscience. 2013 Jul 23;7:334. doi: 10.3332/ecancer.2013.334. Print 2013.

13.

Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.

Lopez CR, Antoni MH, Pereira D, Seay J, Whitehead N, Potter J, O'Sullivan M, Fletcher MA.

J Appl Biobehav Res. 2013 Mar 1;18(1):37-57. Epub 2013 Mar 8.

14.

High-risk human papillomavirus infection in HIV-positive African women living in Europe.

Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, Larsimont D, Delforge M, De Wit S, Clumeck N.

J Int AIDS Soc. 2013 Feb 14;16:18023. doi: 10.7448/IAS.16.1.18023.

15.

Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.

Rositch AF, Gravitt PE, Tobian AA, Newell K, Quinn TC, Serwadda D, Ssebbowa P, Kiggundu V, Gray RH, Reynolds SJ.

PLoS One. 2013;8(1):e55383. doi: 10.1371/journal.pone.0055383. Epub 2013 Jan 29.

16.

Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.

Couture MC, Page K, Stein ES, Sansothy N, Sichan K, Kaldor J, Evans JL, Maher L, Palefsky J.

BMC Infect Dis. 2012 Jul 28;12:166. doi: 10.1186/1471-2334-12-166.

17.

Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.

Memiah P, Mbuthia W, Kiiru G, Agbor S, Odhiambo F, Ojoo S, Biadgilign S.

AIDS Res Treat. 2012;2012:953743. doi: 10.1155/2012/953743. Epub 2012 Apr 4.

18.

Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia.

White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Kapambwe S, Moneyham L, Kempf MC, Chamot E.

J Psychosom Obstet Gynaecol. 2012 Jun;33(2):91-8. doi: 10.3109/0167482X.2012.656161. Epub 2012 Feb 28.

19.

Review of HIV-Related Cytopathology.

Lang TU, Khalbuss WE, Monaco SE, Michelow P, Pantanowitz L.

Patholog Res Int. 2011 Apr 7;2011:256083. doi: 10.4061/2011/256083.

20.

Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation.

Atashili J, Smith JS, Adimora AA, Eron J, Miller WC, Myers E.

PLoS One. 2011 Apr 4;6(4):e18527. doi: 10.1371/journal.pone.0018527.

Items per page

Supplemental Content

Write to the Help Desk